Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Shenling Baizhu San for Macular Edema
NCT05122702Phase 2Terminated
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jul 2022
- Primary completion
- Mar 2025
- Modality
- Herbal formula
- Countries
- 1
01
Overview
A Phase 2 trial of Modified Shenling Baizhu San in macular edema, sponsored by The Chinese University of Hong Kong. Started Jul 2022; status: terminated.
02
Drugs
Modified Shenling Baizhu San
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT05122702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122702.